Company news
Hyphens Pharma International Ltd. (SGX:1J5) news
Hyphens Pharma International Ltd. news releases on 6ix. Latest, Jan 5, 2026: Hyphens Pharma out‑licences Cerapro® MED Skin Barrier Cream for six European…
Press releases & updates
Hyphens Pharma out‑licences Cerapro® MED Skin Barrier Cream for six European countries
January 5, 2026
Cosmo Announces Launch of Winlevi(R) for Treatment of Acne in Singapore and Malaysia
July 17, 2025
Hyphens Pharma licenses Wynzora Cream for ASEAN countries from MC2 Therapeutics
March 13, 2024
General Announcement::HYPHENS PHARMA HAS INKED EXCLUSIVE LICENSING DEAL OF USTEKINUMAB BIOSIMILAR
December 13, 2021
Asset Acquisitions and Disposals::STRIKING-OFF OF INDIRECT WHOLLY-OWNED SUBSIDIARY, DAC PHARMALAB PTE LTD
December 9, 2021
Asset Acquisitions and Disposals::COMPLETION OF THE PROPOSED ACQUISITION OF 100% OF THE ISSUED SHARE CAPITAL IN NOVEM GROUP
December 3, 2021
General Announcement::ACQUISITION OF NOVEM & 3Q BUSINESS UPDATE
November 16, 2021